New eye drops aim to heal corneal damage in rare disease
Disease control
Recruiting now
This Phase 3 study tests whether RGN-259 eye drops can heal persistent corneal defects in people with neurotrophic keratopathy, a condition where the cornea loses sensation and doesn't heal properly. About 70 adults will use the drops five times daily for 28 days or a placebo. Th…
Phase: PHASE3 • Sponsor: ReGenTree, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC